Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes | ACS Pharmacology & Translational Science
mTORC1 and CB1 receptor signaling regulate excitatory glutamatergic inputs onto the hypothalamic paraventricular nucleus in response to energy availability - ScienceDirect
Exploring CB1, CB2 in Various Neurological Conditions
Frontiers | Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling | Neuropsychopharmacology
IJMS | Free Full-Text | Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Endocannabinoid signalling and the deteriorating brain | Nature Reviews Neuroscience
Frontiers | Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review
Frontiers | Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity | Neuropsychopharmacology
Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy | Nature Reviews Neuroscience
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development | Neuropsychopharmacology
Cannabinoid receptor type-1: breaking the dogmas | F1000Research
Cells | Free Full-Text | Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
IJMS | Free Full-Text | Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
Frontiers | Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Endocannabinoid signaling in astrocytes - Eraso‐Pichot - 2023 - Glia - Wiley Online Library
Pharmaceutics | Free Full-Text | “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
IJMS | Free Full-Text | New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology
Frontiers | Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease
Cannabinoid CB1 and CB2 Receptor Signaling and Bias | Cannabis and Cannabinoid Research
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system | PLOS ONE
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology
IJMS | Free Full-Text | Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
Cannabinoids and the expanded endocannabinoid system in neurological disorders | Nature Reviews Neurology
